Physician profile
Irvin Benowitz
NPI 1083749212
$309.51
in general payments reported to CMS, 2019-2025
10 companies · $44.14 in 2025
The $44.14 reported for 2025 was less than what a typical Geriatric Medicine (Family Medicine) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.18 · 2020: $108 · 2021: $60.56 · 2024: $61.34 · 2025: $44.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $105.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $69.18 | 2020-2021 | |
| Dexcom, INC. | $61.34 | 2024 | Dexcom G6 Transmitter |
| Amgen INC. | $32.06 | 2020 | |
| Indivior INC. | $30.00 | 2020 | |
| Abbott Laboratories | $26.24 | 2025 | Id Now Instrument |
| Abbvie INC. | $26.15 | 2021 | |
| Lilly USA, LLC | $20.87 | 2019 | |
| Phadia US INC. | $17.90 | 2025 | Immunocap |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.31 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $11.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irvin Benowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.